Skip to main content

Table 4 Ranking of SF-36/SF-12 Algorithm by Estimated Incremental Cost Utility Ratio

From: Are decisions using cost-utility analyses robust to choice of SF-36/SF-12 preference-based algorithm?

 

Incremental Cost

1 year QALYs Gained

ICUR ($/QALY) [95% CI]

Rank

Asthma

    

   Lawrence (SF-12, EQ-5D)

$2000

0.065

30 769 [26 316, 36 697]

1

   Franks (SF-12, EQ-5D, MEPS)

$2000

0.065

31 008 [26 490, 37 383]

2

   Franks (SF-12, HUI3)

$2000

0.061

33 058 [27 778, 40 816]

3

   Franks (SF-12, EQ-5D)

$2000

0.058

34 783 [28 986, 43 011]

4

   Lundberg (SF-12, VAS)

$2000

0.046

43 956 [37 383, 52 632]

5

   Shmueli (SF-36, VAS)

$2000

0.042

47 619 [40 816, 57 971]

6

   Nichol (SF-36, HUI2)

$2000

0.038

53 333 [44 444, 66 667]

7

   Fryback (SF-36, QWB)

$2000

0.033

60 606 [53 333, 70 175]

8

   Brazier (SF-12, SG)

$2000

0.033

61 538 [51 282, 85 106]

9

   Brazier (SF-36, SG)

$2000

0.032

63 492 [48 780, 83 333]

10

Stroke

    

   Lawrence (SF-12, EQ-5D)

$2000

0.067

29 851 [22 599, 43 956]

3

   Franks (SF-12, EQ-5D, MEPS)

$2000

0.072

27 972 [20 942, 41 667]

1

   Franks (SF-12, HUI3)

$2000

0.067

30 075 [22 599, 44 944]

4

   Franks (SF-12, EQ-5D)

$2000

0.070

28 777 [20 942, 45 455]

2

   Lundberg (SF-12, VAS)

$2000

0.040

50 000 [35 088, 88 889]

8

   Shmueli (SF-36, VAS)

$2000

0.028

72 727 [48 780, 148 148]

10

   Nichol (SF-36, HUI2)

$2000

0.045

44 944 [33 058, 68 966]

6

   Fryback (SF-36, QWB)

$2000

0.035

57 971 [44 944, 83 333]

9

   Brazier (SF-12, SG)

$2000

0.044

45 977 [33 058, 74 074]

7

   Brazier (SF-36, SG)

$2000

0.058

34 483 [27 211, 46 512]

5

  1. NB: algorithms are ordered from lowest to highest ICUR in the asthma patients